Omega Therapeutics, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Omega Therapeutics reported its Q3 2024 financial results, highlighting a strategic prioritization aimed at extending its cash runway into the second quarter of 2025.
Omega Therapeutics' Q2 2024 report highlights a strategic prioritization, resulting in reduced operating expenses and a cash runway into Q1 2025.
10-Q: Omega Therapeutics Reports First Quarter 2024 Results, Strategic Prioritization Extends Cash Runway
Omega Therapeutics announced its first quarter 2024 financial results, highlighting a strategic prioritization to extend its cash runway into the first quarter of 2025.